157 related articles for article (PubMed ID: 33159608)
1. Salvage Pelvic Lymph Node Dissection and Current State of Imaging for Recurrent Prostate Cancer: Does a Standard Exist?
McCloskey H; Jacobs J; Zambrano I; Moore T; Khandani AH; Bjurlin MA
Curr Urol Rep; 2020 Nov; 21(12):62. PubMed ID: 33159608
[TBL] [Abstract][Full Text] [Related]
2. Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
Van Eecke H; Devos G; Vansevenant B; Vander Stichele A; Devlies W; Berghen C; Everaerts W; De Meerleer G; Joniau S
Int J Urol; 2023 Jan; 30(1):92-99. PubMed ID: 36305586
[TBL] [Abstract][Full Text] [Related]
3. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P
Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893
[TBL] [Abstract][Full Text] [Related]
4. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
Abdollah F; Briganti A; Montorsi F; Stenzl A; Stief C; Tombal B; Van Poppel H; Touijer K
Eur Urol; 2015 May; 67(5):839-49. PubMed ID: 24698524
[TBL] [Abstract][Full Text] [Related]
5. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH
Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
[TBL] [Abstract][Full Text] [Related]
6. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series.
Bravi CA; Fossati N; Gandaglia G; Suardi N; Mazzone E; Robesti D; Osmonov D; Juenemann KP; Boeri L; Jeffrey Karnes R; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
Eur Urol; 2020 Dec; 78(6):779-782. PubMed ID: 32624281
[TBL] [Abstract][Full Text] [Related]
8. Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer.
Quhal F; Bryniarski P; Rivas JG; Gandaglia G; Shariat SF; Rajwa P
Curr Opin Urol; 2023 Jul; 33(4):269-273. PubMed ID: 37166270
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.
Bravi CA; Fossati N; Gandaglia G; Suardi N; Mazzone E; Robesti D; Osmonov D; Juenemann KP; Boeri L; Jeffrey Karnes R; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
Eur Urol; 2020 Nov; 78(5):661-669. PubMed ID: 32624288
[TBL] [Abstract][Full Text] [Related]
10. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
Winter A; Henke RP; Wawroschek F
BMC Urol; 2015 Feb; 15(1):10. PubMed ID: 25881245
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen-guided salvage lymph node dissection in recurrent prostate cancer: a novel technology to detect lymph node metastases.
Maurer T; Gschwend JE; Eiber M
Curr Opin Urol; 2018 Mar; 28(2):191-196. PubMed ID: 29028767
[TBL] [Abstract][Full Text] [Related]
12. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.
Linxweiler J; Sprenk J; Cascetta K; Pryalukhin A; Hölters S; Zeuschner P; Nini A; Al-Kailani Z; Ezziddin S; Bohle RM; Fries P; Ohlmann CH; Heinzelbecker J; Siemer S; Stöckle M; Junker K; Saar M
J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326
[TBL] [Abstract][Full Text] [Related]
13. Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.
Hiester A; Nini A; Niegisch G; Arsov C; Hautzel H; Antke C; Schimmöller L; Albers P; Rabenalt R
World J Urol; 2019 Oct; 37(10):2081-2090. PubMed ID: 30643974
[TBL] [Abstract][Full Text] [Related]
14. Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.
Knipper S; Tilki D; Mansholt J; Berliner C; Bernreuther C; Steuber T; Maurer T; Graefen M
Eur Urol Focus; 2019 Jan; 5(1):50-53. PubMed ID: 30292421
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
Falkenbach F; Knipper S; Koehler D; Ambrosini F; Steuber T; Graefen M; Budäus L; Eiber M; Lunger L; Lischewski F; Heck MM; Maurer T
World J Urol; 2023 Sep; 41(9):2343-2350. PubMed ID: 37515651
[TBL] [Abstract][Full Text] [Related]
16. Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan.
Otta-Oshiro RJ; Lista-Mateos F; García-Mediero J; Arranz-Arija JA; García-Prado J; Núñez-Mora C
Actas Urol Esp (Engl Ed); 2019; 43(6):331-335. PubMed ID: 30975547
[TBL] [Abstract][Full Text] [Related]
17. Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer.
Rosiello G; Bandini M; Briganti A
Curr Opin Urol; 2019 Nov; 29(6):629-635. PubMed ID: 31503189
[TBL] [Abstract][Full Text] [Related]
18. PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
Schmidt-Hegemann NS; Buchner A; Eze C; Rogowski P; Schaefer C; Ilhan H; Li M; Fendler WP; Bartenstein P; Ganswindt U; Stief C; Belka C; Kretschmer A
Strahlenther Onkol; 2020 Jul; 196(7):637-646. PubMed ID: 32211942
[TBL] [Abstract][Full Text] [Related]
19. Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time?
Suardi N; Briganti A; Gandaglia G; Fossati N; Montorsi F
Eur Urol; 2017 May; 71(5):693-694. PubMed ID: 28043707
[TBL] [Abstract][Full Text] [Related]
20. Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
Fossati N; Suardi N; Gandaglia G; Bravi CA; Soligo M; Karnes RJ; Shariat S; Battaglia A; Everaerts W; Joniau S; Van Poppel H; Rajarubendra N; Gill IS; Larcher A; Mottrie A; Schmautz M; Heidenreich A; Kalz A; Osmonov D; Juenemann KP; Herlemann A; Gratzke C; Stief C; Montorsi F; Briganti A
Eur Urol; 2019 Jan; 75(1):176-183. PubMed ID: 30301694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
